A BioHealth research program selected by the French Ministry of Research and Education in the framework of the "Laboratoires d'Excellence" initiative.
EpiGenMed wants to foster the best BioHealth basic and clinical research and to encourage interdisciplinary projects. The EpiGenMed project was selected by the French Ministry of Research and Education in the framework of the national "Investments for the Future" program in 2011. The project received 12 million euros in funding for a 10-year period, essentially devoted to science training through the recruitment of PhD students, post-doctoral fellows and Chairs of Excellence.
EpiGenMed involves 55 of the best research groups in Montpellier, implicated in five areas of research that cover Genome and Epigenome Dynamics, Cell cycle, Cell fate and Development, Infectious diseases and Immunology, Cell signalling and Neurobiology, Biophysics and Systems biology. It is hosted by the University of Montpellier and national science institutions and benefits from an excellent industrial environment
Labex EpiGenMed PhD Students and Postdocs Day 2016
Discover the diversity of EpiGenMed PhD's and Postdoc's scientific projects on:
October 28th, 2016 at Genopolys Montpellier
Talks and posters by the Labex EpiGenMed PhDs and Postdocs
Invited speaker: Robin A. Weiss
Registration is free but limited to 130 attendants
by email to firstname.lastname@example.org
See you there!
Postdoctoral Program 2015
The Labex (Laboratory of Excellence) EpiGenMed is a collaborative health science research program at the University of Montpellier that is financed by the Excellence Initiative of the French Ministry of Research and that involves leading research laboratories of the area.
Five major axes of research (involving 50 top-level research groups) are supported by this initiative:
• Genomics and Epigenetics
• Cell cycle and Development
• Molecular Basis of Infectious Diseases
• Neuroscience and Cell Signalling
• Biophysics and Systems Biology
The EpiGenMed post-doctoral program offers 10 fellowships for a period of 2 years (1 year renewable), starting on January 1st, 2016.
The selection of candidates will be done by the leaders the EpiGenMed research groups and validated by the Scientific Committee.
Applications should be sent directly to the following team leaders.